Valuation: Entero Healthcare Solutions Limited

Capitalization 5.04TCr 55Cr 47Cr 43Cr 40Cr 75Cr 80Cr 494.26Cr 196.22Cr 2.38TCr 205.71Cr 201.5Cr 8.66TCr P/E ratio 2026 *
35.5x
P/E ratio 2027 * 25.8x
Enterprise value 5.09TCr 55Cr 47Cr 44Cr 41Cr 76Cr 81Cr 499.61Cr 198.35Cr 2.41TCr 207.94Cr 203.68Cr 8.75TCr EV / Sales 2026 *
0.79x
EV / Sales 2027 * 0.61x
Free-Float
35.72%
Yield 2026 *
-
Yield 2027 * -
More valuation ratios * Estimated data
Dynamic Chart
14/11 Jefferies Adjusts Entero Healthcare Solutions' Price Target to INR1,250 From INR1,350, Keeps at Hold MT
14/11 Entero Healthcare Solutions Limited, Q2 2026 Earnings Call, Nov 13, 2025
12/11 Entero Healthcare Solutions Limited Announces Executive Changes, Effective November 12, 2025 CI
12/11 Entero Healthcare Solutions to buy 80% stake in Bioaide Technologies RE
12/11 Entero Healthcare Solutions Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
12/11 Entero Healthcare Solutions Limited executed a definitive agreement to acquire 80% stake in Bioaide Technologies Private Limited for approximately INR 360 million. CI
12/11 Entero Healthcare Solutions Limited entering into a binding memorandum of understanding to acquire 51% stake in Anand Chemiceutics Private Limited for INR 2.3 billion. CI
29/25/29 Yash Sudhir Biradar and Kavita Sudhir Biradar agreed to acquire Suprabhat Pharmaceuticals Private Limited from Entero Healthcare Solutions Limited for INR 3.7 million. CI
29/25/29 Entero Healthcare Solutions Limited signed a letter of intent to acquire 60% stake in Ace Cardiopathy Solutions Private Limited for approximately INR 770 million. CI
22/25/22 Entero Healthcare Solutions Limited(BSE:544122) added to S&P Global BMI Index CI
03/25/03 Entero Healthcare Solutions Limited Announces Change in Corporate Office Address CI
16/25/16 8,700,000 Equity Shares of Entero Healthcare Solutions Limited are subject to a Lock-Up Agreement Ending on 16-AUG-2025. CI
12/25/12 Jefferies Adjusts Entero Healthcare Solutions' Price Target to INR1,350 From INR1,320, Keeps at Hold MT
More news
1 day-1.61%
1 week-4.37%
Current month+12.84%
1 month+19.60%
3 months+3.12%
6 months-3.65%
Current year+12.84%
More quotes
1 week 1,095.1
Extreme 1095.1
1,209.6
1 month 944
Extreme 944
1,247.5
Current year 1,071.1
Extreme 1071.1
1,247.5
1 year 944
Extreme 944
1,563.9
3 years 944
Extreme 944
1,584.25
5 years 944
Extreme 944
1,584.25
10 years 944
Extreme 944
1,584.25
More quotes
Manager TitleAgeSince
Chief Operating Officer 48 10/01/2018
Chief Executive Officer 49 10/01/2018
Compliance Officer 54 16/01/2025
Director TitleAgeSince
Director/Board Member 49 10/01/2018
Director/Board Member 41 25/08/2020
Chairman 60 25/08/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.61%-4.37%-10.91% - 56Cr
-2.19%-11.58%-12.63%-5.57% 19TCr
-0.35%+4.45%+13.24%+22.70% 13TCr
+0.16%-0.55%+42.33%+118.22% 6.86TCr
-1.89%-2.73%-16.23%-19.28% 5.87TCr
+1.35%-0.66%+18.33%+88.44% 5.37TCr
-0.01%+3.88% - - 3.82TCr
-1.30%+4.90%-16.82%-31.44% 2.88TCr
-0.56%-3.41%+19.47%+25.45% 2.56TCr
-1.72%-3.06%+0.10%-34.16% 2.4TCr
Average -0.84%-0.62%+4.10%+20.54% 6.17TCr
Weighted average by Cap. -0.96%-2.95%+3.94%+21.69%
See all sector performances

Financials

2026 *2027 *
Net sales 6.45TCr 70Cr 60Cr 55Cr 52Cr 96Cr 102.16Cr 632.34Cr 251.04Cr 3.04TCr 263.18Cr 257.79Cr 11TCr 8.18TCr 89Cr 76Cr 70Cr 66Cr 122.26Cr 129.58Cr 802.05Cr 318.42Cr 3.86TCr 333.81Cr 326.98Cr 14TCr
Net income 143.25Cr 1.56Cr 1.33Cr 1.23Cr 1.15Cr 2.14Cr 2.27Cr 14Cr 5.58Cr 68Cr 5.85Cr 5.73Cr 246.04Cr 194.15Cr 2.11Cr 1.8Cr 1.67Cr 1.56Cr 2.9Cr 3.08Cr 19Cr 7.56Cr 92Cr 7.92Cr 7.76Cr 333.45Cr
Net Debt 55Cr 59.43L 50.54L 46.85L 43.78L 81.61L 86.5L 5.35Cr 2.13Cr 26Cr 2.23Cr 2.18Cr 94Cr -42Cr -46.26L -39.34L -36.47L -34.08L -63.53L -67.33L -4.17Cr -1.65Cr -20Cr -1.73Cr -1.7Cr -73Cr
More financial data * Estimated data
Logo Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to more than 86,300 retail pharmacies and healthcare practitioners (HCPs) across 540 districts in India. Its portfolio includes 68,900+ SKUs from more than 2000 pharma companies. It is a supplier to over 3,400 hospitals across India, including corporate hospital chains. It sells private label products under its private label, Entero Surgicals. It offers both demand generation and demand fulfilment solutions to healthcare product manufacturers. It has over 79 distribution warehouses located across 39 cities in 19 states and union territories, developed 478,720 square feet of warehousing space with temperature monitoring systems and modern storage solutions. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs.
Employees
4,111
More about the company
Date Price Change Volume
23/26/23 1,158.40 -1.61% 69,539
22/26/22 1,177.30 +6.37% 96,380
21/26/21 1,106.80 -3.28% 2,08,585
20/26/20 1,144.30 -4.71% 1,27,171
19/26/19 1,200.80 +0.74% 60,846

Delayed Quote NSE India S.E., January 23, 2026 at 05:19 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,158.40INR
Average target price
1,416.50INR
Spread / Average Target
+22.28%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ENTERO Stock